CIK 0002123613 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kardigan, Inc.
Sign in to watch- Ticker
- KARD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 932994203
- Phone
- (415) 573-3220
- Business address
- C/O KARDIGAN, INC., 131 OYSTER POINT BLVD., SECOND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-29 | Reinke Kristin Marie K Director | Grant or award · Stock Options (right to buy) | +48,368 | 48,368 | ||
| 2026-06-22 | HRTG GPE, LLC 10% owner | Purchase | +3,125,000 | $16.00 | $50.0M | 14,866,868 |
| 2026-06-22 | BERNS PAUL L Director | Purchase | +1,250,000 | $16.00 | $20.0M | 15,042,035 |
| 2026-06-22 | ARCH Venture Partners XIII, LLC Director | Purchase | +1,250,000 | $16.00 | $20.0M | 15,042,035 |
| 2026-06-17 | PERCEPTIVE ADVISORS LLC Director | Grant or award | +20,706 | 20,706 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion | +2,050,166 | 2,050,166 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion | +6,150,502 | 6,150,502 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion | +3,242,993 | 9,393,495 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion | +2,348,373 | 11,741,868 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −1,287,146 | 0 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion · Series A Redeemable Convertible Preferred Stock | −3,861,440 | 0 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion · Series B Redeemable Convertible Preferred Stock | −2,036,033 | 0 | ||
| 2026-06-17 | HRTG GPE, LLC 10% owner | Conversion · Series B-1 Redeemable Convertible Preferred Stock | −1,474,368 | 0 | ||
| 2026-06-17 | ARCH Venture Partners XIII, LLC Director | Conversion | +13,792,035 | 13,792,035 | ||
| 2026-06-17 | ARCH Venture Partners XIII, LLC Director | Conversion · Series A Preferred Stock | −5,148,587 | 0 | ||
| 2026-06-17 | ARCH Venture Partners XIII, LLC Director | Conversion · Series B Preferred Stock | −1,204,000 | 0 | ||
| 2026-06-17 | ARCH Venture Partners XIII, LLC Director | Conversion · Series B-1 Preferred Stock | −2,306,401 | 0 | ||
| 2026-06-17 | Pasternak Andy Chief Strategy Officer | Grant or award | +79,640 | 79,640 | ||
| 2026-06-17 | Meeker David P Director | Grant or award | +20,706 | 20,706 | ||
| 2026-06-17 | BERNS PAUL L Director | Conversion | +13,792,035 | 13,792,035 |
Page 1 of 2 · 39 trades